Fingerprint
Dive into the research topics of 'Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically